<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.7916/d8-927p-b627</dc:identifier><dc:title>Oral history interview with Bruce Evatt, 1991</dc:title><dc:creator>Evatt, Bruce L</dc:creator><dc:format>oral histories</dc:format><dc:format>sound recordings</dc:format><dc:type>sound recording - nonmusical</dc:type><dc:subject>Hemophilia--History.--United States</dc:subject><dc:subject>Hemophilia--Social aspects</dc:subject><dc:subject>Hemophilia--Political aspects</dc:subject><dc:subject>AIDS (Disease)--History.--United States</dc:subject><dc:subject>Physicians</dc:subject><dc:subject>Evatt, Bruce L</dc:subject><dc:subject>National Hemophilia Foundation</dc:subject><dc:subject>Centers for Disease Control and Prevention (U.S.)</dc:subject><dc:description>Early work in blood coagulation at CDC (Centers for Disease Control), leading to interest in persons with hemophilia; involvement in setting up comprehensive hemophilia care program in Atlanta, Georgia; involvement in helping to develop monoclonal antibody for Factor VIII at CDC; early realization that HIV might be infecting people with hemophilia through the blood supply; difficulties of convincing the Federal Drug Administration, blood banks, and the leadership of the National Hemophilia Foundation that AIDS was transmitted via the blood supply, complicated by a lack of understanding of epidemiological trends; components of the hemophilia community; difficulties in dealing with issues of sexual transmission and HIV testing among people with hemophilia; appearance of HIV in wives of people with hemophilia; issues of funding regarding HIV prevention in people with hemophilia; increased consumer voice among the hemophilia community; "the model" of comprehensive care for hemophilia; importance of looking at individual patients as well as at epidemiological trends; economic issues regarding hemophilia treatment</dc:description></oai_dc:dc>